ATYR PHARMA INC (LIFE)

US0021202025 - Common Stock

1.91  +0.02 (+1.06%)

After market: 1.94 +0.03 (+1.57%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-43.16M-45.34M-33.78M-16.23M-23.76M
Depreciation Amortization
460.00K230.00K480.00K570.00K640.00K
Change In Working Capital
7.37M-830.00K-2.59M-2.26M210.00K
Interest Paid
N/A50.00K0.00310.00K1.12M
Other non cash items
2.81M4.06M2.82M2.62M2.91M
OPERATING CASH FLOW
-32.53M-41.89M-33.08M-15.30M-20.01M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
-5.32M-1.64M-190.00K-200.00K-80.00K
Other Investing Activity
-30.63M48.89M-91.37M7.10M5.00M
INVESTING CASH FLOW
-35.95M47.25M-91.57M6.90M4.93M
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
-330.00K-70.00K0.00-9.08M-8.00M
Stock Issued/Repurchased
61.44M5.52M110.03M25.23M9.34M
Other Financing Activity
N/AN/AN/AN/A0.00
FINANCING CASH FLOW
61.12M5.45M110.03M16.14M1.34M
 
CHANGE IN CASH
-7.36M10.81M-14.62M7.74M-13.74M
 
FREE CASH FLOW
Operating Cash Flow
-32.53M-41.89M-33.08M-15.30M-20.01M
Capital Expenditure
-5.32M-1.64M-190.00K-200.00K-80.00K
FREE CASH FLOW
-37.85M-43.53M-33.27M-15.50M-20.09M

All data in USD

Charts